Briciclib
- Generic Name
- Briciclib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23O10PS
- CAS Number
- 865783-99-9
- Unique Ingredient Identifier
- WG93X96336
- Background
Briciclib has been used in trials studying the treatment of Lymphoma, Neoplasms, Advanced Solid Tumor, and Acute Lymphocytic Leukemia.
- Associated Conditions
- -
- Associated Therapies
- -
Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors
- First Posted Date
- 2014-06-20
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- Traws Pharma, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT02168725
- Locations
- 🇺🇸
University of Colorado Hospital Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath